The inhibitor of CSF-1R, a receptor for macrophage colony-stimulating growth factor, was investigated in mouse models of pancreatic cancer where it decreased the frequencies of TAMs, while increasing IFN production and delaying tumor progression (201, 202). Here, IFNA1 is linked to neoplasm.